Related Experiment Video
Updated: Jul 1, 2025
Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Novel molecular subtypes of intracranial germ cell tumors expand therapeutic opportunities
Bo Li1,2, Shuang Zhao3,4, Shouwei Li5
1Department of Radiation Oncology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
Background:
Intracranial germ cell tumors (IGCTs) are a rare group of malignancies that are clinically classified as germinomas and nongerminomatous germ cell tumors (NGGCTs). Previous studies have found that somatic mutations involving the mitogen-activated protein kinase/mTOR signaling pathway are common early events. However, a comprehensive genomic understanding of IGCTs is still lacking.
Methods:
We established a cohort including over 100 IGCTs and conducted genomic and transcriptomic sequencing.
Results:
We identified novel recurrent driver genomic aberrations, including USP28 truncation mutations and high-level copy number amplification of KRAS and CRKL caused by replication of extrachromosomal DNA. Three distinct subtypes associated with unique genomic and clinical profiles were identified with transcriptome analysis: Immune-hot, MYC/E2F, and SHH. Both immune-hot and MYC/E2F were predominantly identified in germinomas and shared similar mutations involving the RAS/MAPK signaling pathway. However, the immune-hot group showed an older disease onset age and a significant immune response. MYC/E2F was characterized by a younger disease onset age and increased genomic instability, with a higher proportion of tumors showing whole-genome doubling. Additionally, the SHH subtype was mostly identified in NGGCTs.
Conclusions:
Novel genomic aberrations and molecular subtypes were identified in IGCTs. These findings provide molecular basis for the potential introduction of new treatment strategies in this setting.
Insights
This study uncovers new genetic drivers and molecular subtypes in intracranial germ cell tumors (IGCTs), revealing distinct profiles for germinomas and nongerminomatous germ cell tumors (NGGCTs). These findings pave the way for novel therapeutic strategies.
Area of Science:
- Genomics
- Oncology
- Molecular Biology
Background:
- Intracranial germ cell tumors (IGCTs) are rare malignancies classified as germinomas and NGGCTs.
- Previous research indicated frequent RAS/MAPK/mTOR pathway mutations but lacked comprehensive genomic insights.
- A complete understanding of IGCTs' genomic landscape was needed.
Purpose of the Study:
- To perform comprehensive genomic and transcriptomic sequencing of over 100 IGCTs.
- To identify novel driver genomic aberrations and molecular subtypes within IGCTs.
- To establish a molecular basis for developing new treatment strategies.
Main Methods:
- Genomic and transcriptomic sequencing of a cohort exceeding 100 IGCTs.
- Identification of recurrent driver genomic aberrations.
- Transcriptome analysis to classify molecular subtypes.
Main Results:
- Novel recurrent driver genomic aberrations were identified, including USP28 truncations and KRAS/CRKL amplifications from extrachromosomal DNA.
- Three distinct molecular subtypes were discovered: Immune-hot, MYC/E2F, and SHH.
- Immune-hot and MYC/E2F subtypes, primarily in germinomas, showed RAS/MAPK pathway mutations, with Immune-hot exhibiting immune response and older onset, and MYC/E2F showing genomic instability and younger onset.
- The SHH subtype was predominantly found in NGGCTs.
Conclusions:
- Novel genomic aberrations and molecular subtypes in IGCTs have been identified.
- These discoveries offer a molecular foundation for advancing treatment strategies for IGCTs.
- The findings highlight distinct molecular profiles that could inform personalized therapeutic approaches.
